Search for: "Unite Here v. Food and Drug Administration" Results 1 - 20 of 445
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2008, 3:53 pm
Approval of drugs by the Food and Drug Administration (FDA) should not preempt any liability under state tort laws for pharmaceutical manufacturers, editors of the New England Journal of Medicine argue in a brief to the United States Supreme Court. [read post]
12 Mar 2009, 3:44 am
As we discussed here, the United States Supreme Court last week ruled that state law claims for failure to include an adequate warning on a pharmaceutical label are not preempted by the federal Food and Drug Administration’s (“FDA”) prior approval of the product’s label. [read post]
22 Jul 2019, 9:03 pm by News Desk
Without much attention last November, on behalf of the Food and Drug Administration (FDA), U.S. [read post]
14 Jul 2020, 9:01 pm by Guest Opinion
Food and Drug Administration has released its blueprint for agency’s “New Era of Smarter Food Safety. [read post]
6 Nov 2008, 2:53 pm
  This case involves the question whether the Food and Drug Administration’s (“FDA”) regulation of prescription drug labeling pursuant to Federal Food, Drug, and Cosmetic Act, 21 U.S.C. [read post]
26 Mar 2024, 9:21 am by Robin Frazer Clark
Today the United States Supreme Court is hearing oral arguments in Case No. 23-235 FOOD AND DRUG ADMINISTRATION V. [read post]
30 Jun 2011, 4:30 am by Laura Simons
We recently reported here that a South Carolina family-owned tomato farm had sued the United States Food and Drug Administration (FDA) in South Carolina federal court in Beaufort, alleging that the agency was negligent in its issuing of a 2008 nationwide tomato recall. [read post]
28 Feb 2014, 6:43 am by Christine Nielsen Czuprynski
The Fourth Circuit rejected plaintiff’s claim that Omnicare violated the FCA when it sought reimbursement for drugs that it allegedly packaged in violation of the Food and Drug Administration's (FDA) Current Good Manufacturing Practices regulations (cGMP). [read post]
3 Nov 2009, 1:25 am
United States, Docket No. 09-cv-01879 (D.D.C.).Allergan’s complaint argues that the Food, Drug, & Cosmetic Act does not prohibit the prescription or administration of off-label uses of legal drugs, and that such off-label uses are in fact quite common. [read post]
5 Mar 2009, 1:30 am
By a 6-3 vote, the United States Supreme Court yesterday found that state law claims for failure to include an adequate warning on a pharmaceutical label are not preempted by the federal Food and Drug Administration’s (“FDA”) prior approval of the product’s label. [read post]
13 Oct 2010, 1:35 pm by admin
  According to AARP, “the risky devices are not approved by the Food and Drug Administration (FDA) as safe and effective to treat vascular disease, which involves narrowing of blood vessels in the legs, arms, or kidneys. [read post]
1 Nov 2011, 4:35 am by Cal Warriner
Federal preemption is based upon the ridiculous concept that Food & Drug Administration (FDA) approval means a product is safe and that its warnings are adequate. [read post]